Dogwood Therapeutics, Inc. Shareholders' Equity
Dogwood Therapeutics, Inc. (DWTX) had Shareholders' Equity of $68.37 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $68.37M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $80.62M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $74.90M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $7.26M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $68.37M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $80.62M 10-Q · filed 2026-08-14 |
| 2025-12-31 | $74.90M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $7.26M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $6.88M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $7.09M 10-Q · filed 2026-08-14 |
| 2024-12-31 | -$10.12M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $949.43K 10-Q · filed 2025-11-07 |
| 2024-06-30 | $3.14M 10-Q · filed 2025-11-07 |
| 2024-03-31 | $2.65M 10-Q · filed 2025-11-07 |
| 2023-12-31 | $3.81M 10-K · filed 2026-03-18 |
| 2023-09-30 | $4.76M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $4.69M 10-Q · filed 2024-11-08 |
| 2023-03-31 | $5.97M 10-Q · filed 2024-11-08 |
| 2022-12-31 | $7.33M 10-K · filed 2025-03-31 |
| 2022-09-30 | $9.22M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $7.14M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $10.67M 10-Q · filed 2023-11-13 |
| 2021-12-31 | $14.50M 10-K/A · filed 2024-03-08 |
| 2021-09-30 | $18.88M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $22.86M 10-Q · filed 2022-11-14 |
| 2021-03-31 | $27.11M 10-Q · filed 2022-11-14 |
| 2020-12-31 | $29.94M 10-K · filed 2023-03-14 |
| 2019-12-31 | -$5.02M 10-K · filed 2022-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |